Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,...
Reexamination Certificate
2006-05-30
2006-05-30
Spector, Lorraine (Department: 1646)
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
C514S012200, C530S388220, C530S391100, C530S501000
Reexamination Certificate
active
07052695
ABSTRACT:
The invention generally relates to angiogenic factors and more particularly to the angiopoietin family of growth factors and to methods of using these growth factors to induce vasodilation and hypotension and reducing hypertension.
REFERENCES:
patent: 6482406 (2002-11-01), Stewart
patent: 6592864 (2003-07-01), Stewart
patent: WO 96/11269 (1996-04-01), None
patent: WO96/31598 (1996-10-01), None
patent: WO 97/48804 (1997-12-01), None
patent: WO 98/05779 (1998-02-01), None
patent: WO 00/37642 (2000-06-01), None
Koblizek et al., Angiopoietin-1 induces sprouting angiogenesis in vitro, Curr. Biol., 9:529-532, 1998.
Jain et al., Leaky vessels? Call Ang1! Nat. Med., 6(2):131-132, Feb. 2000.
Angiopoietin-1 protects the adult vasculature against plasma leakage, Nat. Med., 6(4):460-463, Apr. 2000.
Zhang et al., Angiopoietin-1 reduces crebral blood vessel leakage and ischemic lesion volume after focal cerebral embolic ischemia in mice, Neurosci., 113(3):683-687, 2002.
Ganong, W.F.(1995), Review of Medical Physiology, 17thEd. (Appleton & Lange:Norwalk CT), p. 630.
Kido et al., Gene transfer of a TIE2 receptor antagonist prevents pulmonary hypertension in rodents, J. Thor. Cardiovascular Surg. 129:268-76, Feb 2005.
Rudge et al., Angiopoietin-1 and pulmonary hypertension: Cause or Cure? Circ. Res. 92:947-949, 2003.
Zhao et al., Protective role of angiopoietin-1 in experimental pulmonary hypertension, Circ. Res. 92 :984-91, 2003.
Videm, V. A new animal model for pulmonary hypertension based on the overexpression of a single gene, angiopoietin-1: Invited commentary, Ann. Thorac. Surg. 77(2):456-457, 2004.
Humbert et al., Cellular and molecular pathobiology of pulmonary arterial hypertension, J. Am. Coll. Cardiol. 43:13S-24S, 2004.
Davis,S., et al., 1996, “Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion trap expression cloning”, Cell 87:1161-1169.
Gregg, Esq. Valeta
Kaufman Claire M.
Regeneron Pharmaceuticals Inc.
Spector Lorraine
LandOfFree
Angiopoietins and methods of treating hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiopoietins and methods of treating hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiopoietins and methods of treating hypertension will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3586666